Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00544713 · ClinicalTrials.gov registry record · NA
Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT00544713 is a NA study that has completed, run by Allergan. The registered enrollment target is 228 participants.
The verdict
NCT00544713, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery
Interventions
- DRUG Carboxymethylcellulose and Glycerin based artificial tear
- DRUG Carboxymethylcellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00544713
The ClinicalTrials.gov registry entry for NCT00544713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carboxymethylcellulose and Glycerin based artificial tear is the first listed.
NCT00544713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00544713 about?
NCT00544713 is a clinical study titled "Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery". This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery
What is the current status of trial NCT00544713?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2007-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00544713?
The interventions under investigation include: Carboxymethylcellulose and Glycerin based artificial tear (DRUG), Carboxymethylcellulose (DRUG).
Who is sponsoring clinical trial NCT00544713?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.